Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 14, Issue 8

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 14, Issue 8 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 8 (2015)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program

Mercedes Salgado Fernández, Maria Teresa Pérez Hoyos, Isabela Díaz de Corcuera, Alba Vidal Arbués & Marta García de la Torre

Pages: 1171-1179

Published online: 16 Jun 2015

AbstractforAflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program | Full Text | References | PDF (360 KB)

463 Views
7 CrossRef citations
0Altmetric

Review

Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis

Britta Galling MD, Maryam A Garcia MD, Uzoma Osuchukwu MD, Katsuhiko Hagi PhD & Christoph U Correll MD

Pages: 1181-1199

Published online: 24 Jun 2015

AbstractforSafety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis | Full Text | References | PDF (455.9 KB)

444 Views
18 CrossRef citations
0Altmetric

Safety of aromatase inhibitor therapy in breast cancer

Anneleen Lintermans PhD & Patrick Neven PhD MD

Pages: 1201-1211

Published online: 09 Jun 2015

AbstractforSafety of aromatase inhibitor therapy in breast cancer | Full Text | References | PDF (300.4 KB)

544 Views
21 CrossRef citations
0Altmetric

Adverse events associated with somatostatin analogs in acromegaly

Ludovica FS Grasso, Renata S Auriemma, Rosario Pivonello & Annamaria Colao

Pages: 1213-1226

Published online: 17 Jul 2015

AbstractforAdverse events associated with somatostatin analogs in acromegaly | Full Text | References | PDF (315 KB)

557 Views
31 CrossRef citations
0Altmetric

Safety of anticoagulant treatment in cancer patients

Ineke Theodora Wilts MD, Suzanne Mariëlla Bleker MD, Nick Van Es MD, Harry Roger Büller MD PhD, Marcello Di Nisio MD PhD & Pieter Willem Kamphuisen MD PhD

Pages: 1227-1236

Published online: 10 Jun 2015

AbstractforSafety of anticoagulant treatment in cancer patients | Full Text | References | PDF (366.2 KB)

302 Views
6 CrossRef citations
0Altmetric

Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia

Adamantia Liapikou (Consultunt of Respiratory Medicine) (Director) (Professor of Respiratory Medicine, Director of ICU) PhD, Michael Toumbis MD PhD & Antoni Torres

Pages: 1237-1247

Published online: 25 Jun 2015

AbstractforManaging the safety of inhaled corticosteroids in COPD and the risk of pneumonia | Full Text | References | PDF (259.3 KB)

549 Views
11 CrossRef citations
0Altmetric

Influenza vaccination in patients with end-stage renal disease

Nicola Principi, Susanna Esposito & for the ESCMID Vaccine Study Group (EVASG)

Pages: 1249-1258

Published online: 04 Jun 2015

AbstractforInfluenza vaccination in patients with end-stage renal disease | Full Text | References | PDF (236.8 KB)

324 Views
6 CrossRef citations
0Altmetric

Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?

Pascal Richette, Augustin Latourte & Aline Frazier

Pages: 1259-1268

Published online: 01 Jul 2015

AbstractforSafety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend? | Full Text | References | PDF (260.5 KB)

1263 Views
41 CrossRef citations
0Altmetric

Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives

Laura Poupon MSc, Nicolas Kerckhove PhD, Julie Vein PhD DVM, Sylvain Lamoine MSc, Nicolas Authier PhD MD PharmD, Jérôme Busserolles PhD & David Balayssac PhD PharmD

Pages: 1269-1282

Published online: 10 Jun 2015

AbstractforMinimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives | Full Text | References | PDF (305 KB)

858 Views
24 CrossRef citations
0Altmetric

Meta-Opinion

Dose tailoring of dabigatran etexilate: obvious or excessive?

Jonathan Douxfils (PhD Student) PharmD PhD, François Mullier PharmD PhD & Jean-Michel Dogné (Professor) PharmD PhD

Pages: 1283-1289

Published online: 21 May 2015

AbstractforDose tailoring of dabigatran etexilate: obvious or excessive? | Full Text | References | PDF (193.2 KB)

276 Views
20 CrossRef citations
0Altmetric

Drug Safety Evaluation

Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder

Mayce Al-Sukhni (Clinical Pharmacist) BScPhm PharmD, Nadia A Maruschak (Research Assistant) HBSc & Roger S McIntyre (Professor of Psychiatry and Pharmacology) MD FRCPC

Pages: 1291-1304

Published online: 28 May 2015

AbstractforVortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder | Full Text | References | PDF (318 KB)

15043 Views
45 CrossRef citations
0Altmetric

Free Access

Safety evaluation of olaparib for treating ovarian cancer

Stephanie Lheureux MD, PhD, Valerie Bowering RN CON(C), Katherine Karakasis MSc & Amit M Oza BSc, FRCPC, MBBS, MD

Pages: 1305-1316

Published online: 08 Jun 2015

AbstractforSafety evaluation of olaparib for treating ovarian cancer | Full Text | References | PDF (304.9 KB)

778 Views
11 CrossRef citations
0Altmetric

Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C

Yousef Fazel BS, Brian Lam PA-C, Pegah Golabi MD & Zobair Younossi MD MPH

Pages: 1317-1326

Published online: 04 Jun 2015

AbstractforSafety analysis of sofosbuvir and ledipasvir for treating hepatitis C | Full Text | References | PDF (412.4 KB)

950 Views
18 CrossRef citations
0Altmetric

Low-dose SoluMatrix diclofenac: a review of safety across two Phase III studies in patients with acute and osteoarthritis pain

Allan Gibofsky (Professor of Medicine and Public Health) MD, Roy Altman (Professor of Medicine) MD, Stephen Daniels (Executive Medical Director) , Olaolu Imasogie (Senior Vice President) MD & Clarence Young (Chief Medical Officer) MD

Pages: 1327-1339

Published online: 25 May 2015

AbstractforLow-dose SoluMatrix diclofenac: a review of safety across two Phase III studies in patients with acute and osteoarthritis pain | Full Text | References | PDF (228.8 KB)

229 Views
2 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Zhou Zhu et al.

Article | Published online: 17 May 2024

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study

Haiying Ding et al.

Review Article | Published online: 16 May 2024

Adverse tumor events induced by Ranitidine: an analysis based on the FAERS Database

Tian Liu et al.

Article | Published online: 16 May 2024

Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Guixiang Chen et al.

Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.14, Iss.8, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?